1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO DE INDUCCIÓN MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE UPADACITINIB (ABT-494) EN SUJETOS CON ENFERMEDAD DE CROHN DE MODERADA A GRAVE QUE HAN TENIDO UNA RESPUESTA INSUFICIENTE O INTOLERANCIA A UN TRATAMIENTO BIOLÓGICO.

ESTUDIO DE INDUCCIÓN MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE UPADACITINIB (ABT-494) EN SUJETOS CON ENFERMEDAD DE CROHN DE MODERADA A GRAVE QUE HAN TENIDO UNA RESPUESTA INSUFICIENTE O INTOLERANCIA A UN TRATAMIENTO BIOLÓGICO.

Datos básicos

Código:
M14-431
Protocolo:
M14-431
EUDRACT:
2017-001226-18
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2019
Año de finalización:
2021
ENSAYO CLÍNICO INTERNACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ABBVIE DEUTSCHLAND GMBH & CO. KG

Resultados del Ensayo Clínico

2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11611. 2021


A long-term prospective study of the efficacy and safety of endoscopic septotomy using the LigaSure (R) system for the treatment of Zenker's diverticulum

Pons-Beltran, V; (...); Arguello, L

Article. 10.17235/reed.2019.5915/2018. 2019


A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F; (...); Martínez-Olmos J

Article. 10.1007/s41669-020-00201-2. 2020


A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020


A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.

Cerrillo E; (...); Beltrán B

Article. 10.1093/ibd/izz053. 2019


A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial

Del Hoyo, Javier; (...); Aguas, Mariam

Article. 10.2196/11602. 2018


A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial

Aguas, Mariam; (...); Nos, Pilar

Article. 10.2196/resprot.9639. 2018


Acute myocardial infarction in a patient with a recent diagnosis of Crohn's disease

Navarro, B; (...); Iborra, M

Editorial Material. 10.1016/j.gastrohep.2018.05.008. 2019


Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.

Cañete F; (...); ENEIDA registry by GETECCU

Article. 10.1093/ibd/izz084. 2019


Adaptation of TECCU App Based on Patients ' Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups

Del Hoyo, J; (...); Aguas, M

Article. 10.3390/ijerph17061871. 2020


Adaptation of TECCU App based on patients' perceptions for telemonitoring inflammatory bowel disease: A qualitative study using focus groups

Francisco, JD; (...); Aguas, M

Meeting Abstract. 2020


Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020


Alopurinol-induced TEN and association with HLA B*58:01 in White patients

Saavedra, FP; (...); Romero, LCL

Letter. 10.1097/FPC.0000000000000358. 2018


Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019


Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

Bastida, G; (...); Barreiro-de Acosta, M

Meeting Abstract. 10.1093/ecco-jcc/jjy222.251. 2019


Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

Canete, F; (...); Domenech, E

Article. 10.14309/ctg.0000000000000218. 2020


Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

Chaparro, M; (...); EXIT Study Grp GETECCU

Article. 10.1177/1756284819874202. 2019


Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease

SÁEZ, E.; (...); BELTRÁN, B.

Article. 10.3390/nu11051062. 2019


Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2018.12.027. 2019


Biomarkers response to anti-TNF treatment in Crohn's disease through the intestinal microbiota

Sanchis, L; (...); Cortes, X

Meeting Abstract. 2020


Certification of integral care IBD Units: Evaluation of a certification program (CUE)

Barreiro-de Acosta, M; (...); GETECCU

Meeting Abstract. 2020


Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

Guerra I; (...); Gisbert JP

Article. 10.1093/ecco-jcc/jjz094. 2019


Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019


Colorectal cancer diagnosis in patients with inflammatory bowel disease in Spain: A room for improvement

Saldana, R; (...); Mateu, PN

Meeting Abstract. 2020


Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020


COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

  • Open Access.

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020


Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial.

Del Hoyo J, Aguas M

Letter. 10.1016/j.cgh.2020.06.016. 2021


COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020


Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1111/hae.13733. 2019


Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019


Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.

Guasch M; (...); Domènech E

Article. 10.1111/jgh.15084. 2020


Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study

Cabre, E; (...); Domenech, E

Article. 10.1016/j.dld.2018.12.004. 2019


Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019


Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019


DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019


DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019


Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019


Diagnostic yield of endoscopic ultrasound with fine-needle aspiration in pancreatic cystic lesions.

Argüello L; (...); Pons-Beltrán V

Article. 10.1016/j.gastrohep.2019.07.012. 2020


Different Genetic Expression Profiles of Oxidative Stress and Apoptosis-Related Genes in Crohn's Disease

Iborra, M; (...); Beltran, B

Article. 10.1159/000493726. 2019


Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn's disease

Mateos, B; (...); Beltran, B

Meeting Abstract. 10.1093/ecco-jcc/jjy222.725. 2019


DNA methylation signatures associated with pathogenesis Crohn's disease-related genes

Tatay, IM; (...); Beltran, B

Meeting Abstract. 2019


Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis

Taxonera, C; (...); Alba, C

Article. 10.1080/03007995.2019.1579557. 2019


Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.

Rodríguez-Lago I; (...); Gisbert JP

Article. 10.1177/2050640620947579. 2020


Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry. Authors' reply

Iborra, M, Beltran, B, Nos, P

Editorial Material. 10.1111/apt.15447. 2019


Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020


Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Casanova MJ; (...); Gisbert JP

Article. 10.1093/ibd/izz192. 2020


Effectiveness and Safety of the Switch from Remicade (R) to CT-P13 in Patients with Inflammatory Bowel Disease

Chaparro, M; (...); Gisbert, JP

Article. 10.1093/ecco-jcc/jjz070. 2019


Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from Eneida Registry

Chaparro, M; (...); Esteve M

Meeting Abstract. 10.1093/ecco-jcc/jjz203.563. 2020


Efficacy of ustekinumab for the prevention of postoperative recurrence in crohn's disease. Data from clinical practice from the eneida registry

Ciria, MM; (...); Domenech, E

Meeting Abstract. 2020


Endoluminal radiofrequency ablation with SpyGlass in the management of cholangiocarcinoma.

Mansilla-Vivar R; (...); Pons-Beltrán V

Article. 10.17235/reed.2019.6230/2019. 2019


Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study.

Barreiro-De Acosta, M; (...); Julia, B

Article. 10.1080/17474124.2019.1626717. 2019


EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Chaparro M; (...); Gisbert JP

Article. 10.1177/1756284819847034. 2019


Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Chaparro, M; (...); EpidemIBD Grp

Meeting Abstract. 10.1093/ecco-jcc/jjy222.914. 2019


Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU

Chaparro, M; (...); Gisbert, JP

Meeting Abstract. 2020


Epigenetics of Inflammatory Bowel Disease: Unraveling Pathogenic Events

Mateos, Beatriz; (...); Sandoval, Juan

Review. 10.1093/crocol/otz017. 2019


EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019


EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019


Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.

Algaba A; (...); Bermejo F

Article. 10.1007/s10620-020-06424-x. 2020


Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019


Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis.

Ladrón Abia P; (...); Bastida Paz G

Letter. 10.1016/j.gastrohep.2020.07.020. 2021


Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

Chaparro, M; (...); Gisbert, JP

Meeting Abstract. 2019


Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.

Chaparro M; (...); Gisbert JP

Article. 10.1177/1756284819867848. 2019


Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's disease.

Aterido, A; (...); Julia, A

Article. 10.1038/s41397-019-0090-4. 2019


Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.

Del Hoyo J; (...); Aguilera V

Editorial Material. 10.1111/jgh.15174. 2020


Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease.

Moret-Tatay I; (...); Beltrán B

Article. 10.14309/ctg.0000000000000083. 2019


Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study

de Paredes, AGG; (...); Lopez-Sanroman, A

Article. 10.1016/j.pan.2020.02.007. 2020


Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020


Impact of comorbidities on anti-TNF alpha response and relapse in patients with inflammatory bowel disease: the VERNE study

Marin-Jimenez, I; (...); Barreiro-de Acosta, M

Article. 10.1136/bmjgast-2019-000351. 2020


Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study

Marin-Jimenez, I; (...); Barreiro-de Acosta, M

Meeting Abstract. 10.1093/ecco-jcc/jjy222.433. 2019


Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020


Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019


Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020


Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?

Del Hoyo, J, Aguas, M

Editorial Material. 10.1016/j.gastrohep.2020.05.002. 2020


Increased risk of thiopurine-related adverse events in elderly patients with IBD

Calafat, M; (...); ENEIDA Registry GETECCU

Article. 10.1111/apt.15458. 2019


Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019


Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients

Lopez-Munoz, P; (...); Iborra, M

Article. 10.3390/nu11051059. 2019


Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019


Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020


Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020


Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multi-centre cohort study of the ENEIDA registry

Calafat, M; (...); ENEIDA Registry GETECCU

Meeting Abstract. 10.1093/ecco-jcc/jjy222.548. 2019


Management and outcomes of patients with Crohn's disease with first vs multiple surgeries: results from the PRACTICROHN study

Iborra, M; (...); Domenech, E

Article. 10.1093/gastro/goz029. 2019


Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey

Rodriguez-Lago, I; (...); Gisbert, JP

Article. 10.1016/j.gastrohep.2018.09.002. 2019


Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020


Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Multiple duodenal diverticulosis as a rare cause of gastroduodenal bleeding.

Martínez Delgado S; (...); Alonso Lázaro N

Article. 10.1016/j.gastrohep.2020.07.029. 2022


New management of hepatolithiasis: Can surgery be avoided? (with video)

Mansilla-Vivar R; (...); Pons-Beltrán V

Article. 10.1016/j.gastrohep.2019.11.008. 2020


Non-guided self-learning program for high-proficiency optical diagnosis of diminutive and small colorectal lesions: A single-endoscopist pilot study

Bustamante-Balen, M; (...); Pons-Beltran, V

Article. 10.3748/wjg.v25.i10.1278. 2019


Oral ingestion versus endoscopic delivery of endoscopic capsule in patients with previous gastrointestinal surgery (ORENCES study): A Spanish multicentre observational study.

Giordano, Antonio; (...); SEED Group of Capsule Endoscopy and Enteroscopy

Article. 10.1016/j.gastrohep.2020.11.005. 2021


Oxidative Stress in the Pathogenesis of Crohn's Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics

Alemany-Cosme, E; (...); Beltran, B

Review. 10.3390/antiox10010064. 2021


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020


Periendoscopic management of antiplatelet therapy: Prospective evaluation of adherence to guidelines

Plume, G; (...); Bustamante-Balen, M

Article. 10.1016/j.gastrohep.2019.03.010. 2019


Peroral cholangiopancreatoscopy as a rescue method for a trapped pancreatic guidewire

Mansilla-Vivar, R; (...); Beltran, VP

Editorial Material. 10.1055/a-0820-1160. 2019


Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020


PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020


Plasma Oncostatin M, TNF-a, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.

Mateos B; (...); Beltrán B

Article. 10.1159/000508069. 2020


PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019


Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021


Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry

Masnou, H; (...); Eneida-GETECCU Registry

Meeting Abstract. 2020


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021


Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial

Taxonera, C; (...); Nos, P

Article. 10.1016/j.dld.2019.01.002. 2019


Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients.

Iborra M; (...); Nos P

Article. 10.1038/s41598-020-73577-0. 2020


Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients

Iborra, M; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.683. 2019


Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry

Iborra, M; (...); Nos, P

Article. 10.1111/apt.15958. 2020


Real-world long-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA registry

Iborra Colomino, M. I.; (...); Nos, P.

Meeting Abstract. 2020


Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry

Iborra, M; (...); Chaparro, M

Article. 10.1111/apt.15371. 2019


Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry

Iborra, M; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.629. 2019


Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015

Gonzalez, J; (...); Cohort Spanish HIV Res Network Co

Article. 10.1016/j.eimc.2019.02.007. 2019


Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis

Gonzalez-Lama, Y; (...); Gomollon, F

Article. 10.1016/j.gastrohep.2020.01.005. 2020


Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.

Boscá MM; (...); Hinojosa J

Review. 10.1016/j.gastrohep.2019.09.012. 2020


Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.

Barreiro-de Acosta M; (...); Nos P

Editorial Material. 10.1016/j.gastrohep.2019.08.001. 2019


Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.

Barreiro-de Acosta M; (...); Nos P

Article. 10.1016/j.gastrohep.2020.04.004. 2020


Regression of a giant pseudopolyp in a patient with colonic Crohn's disease after therapy with infliximab.

Sánchez Melgarejo JF; (...); Nos P

Article. 10.17235/reed.2019.6252/2019. 2019


Relevance of dynamic studies with magnetic resonance enterography in Crohn's disease.

Pous S; (...); Nos P

Article. 10.1016/j.gastrohep.2019.11.010. 2020


Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry

Calafat, M; (...); Domenech, E

Meeting Abstract. 10.1093/ecco-jcc/jjy222.561. 2019


Risk of postoperative morbidity in patients having bowel resection for colonic Crohn's disease

Iesalnieks I; (...); El-Hussuna A

Article. 10.1007/s10151-018-1904-0. 2018


Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome: Life-Threatening Complications of Anti-TNF-alpha Treatment for Crohn's Disease

Saez-Gonzalez, E; (...); Beltran, B

Letter. 10.1038/s41395-018-0420-1. 2019


Secukinumab-induced ulcerative colitis: opening Pandora's box of immunity

Fernandez-de La Varg, M; (...); Paz, GB

Letter. 10.1016/j.gastrohep.2019.12.004. 2020


SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020


Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease

Taxonera, C; (...); CONVERT Study Grp GETECCU

Article. 10.1093/ecco-jcc/jjy104. 2018


Should professionals provide their patients with digital health training resources?

Piudo, AE; (...); Marcos, NM

Meeting Abstract. 2020


Skin injuries associated with biological therapy in inflammatory bowel disease: beyond psoriasis.

Mínguez Sabater A; (...); Bastida G

Article. 10.1016/j.gastrohep.2020.09.003. 2022


Specific plasma micro-RNA profiles for prediction of recurrence in Crohn's disease in pre-surgery and established recurrence scenarios

Moret, I; (...); Beltran, B

Meeting Abstract. 2020


Survey of adherence to treatment in inflammatory bowel disease. ENADEII study.

Alonso-Abreu I; (...); Quintero-Carrión E

Article. 10.1016/j.gastrohep.2019.10.007. 2020


Survey of adherence to treatment in inflammatory bowel disease: ENADEII STUDY

Abreu, IA; (...); GETECCU

Meeting Abstract. 2019


Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.

Calafat M; (...); Domènech E

Article. 10.1093/ecco-jcc/jjaa055. 2020


Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis.

Del Hoyo J; (...); Aguas M

Article. 10.2196/15505. 2019


The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions.

Zabana Y; (...); Domènech E

Article. 10.1016/j.gastrohep.2020.05.007. 2020


The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus.

Gutierrez-Ontalvilla P; (...); Vicente D

Letter. 10.1684/ejd.2019.3580. 2019


The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study.

Echarri A; (...); Muñiz J

Article. 10.1089/tmj.2018.0264. 2020


Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.

Chaparro M; (...); Gisbert JP

Article. 10.1093/ecco-jcc/jjaa145. 2021


Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020


Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020


Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020


Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

Borras, N; (...); Corrales, I

Article. 10.3324/haematol.2018.203166. 2019


Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018


USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

  • Open Access.

Use of Magnetic Resonance Index of Activity (MaRIA) in the preoperative assessment of small bowel Crohn's disease.

Pous-Serrano, S; (...); Garcia-Granero, E

Article. 10.1016/j.ciresp.2019.06.018. 2019


Use of mycophenolate mofetil in inflammatory bowel disease: results from the ENEIDA registry

Camba, AH; (...); Ramos, L

Meeting Abstract. 2020


Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease

Chaparro, M; (...); Gisbert, JP

Article. 10.1097/MEG.0000000000001706. 2020


Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

Iborra, M; (...); Nos, P

Article. 10.1016/j.gastrohep.2018.06.001. 2018


Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse

Iborra, M; (...); Nos, P

Article. 10.1007/s10620-018-5429-1. 2019


Campos de estudio

Compartir